Product Information
LORAZEPAM 2 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.0696 per EA under NDC 13107008505. Its NADAC has been published 124 times since Feb 14, 2024.
Strength
2 mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107008505
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA203572On Market Since
2/1/2021
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 2 MG TABLET has been published 124 times since Feb 14, 2024, and over the history we have for it it has declined 9.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0696 per EA |
|---|---|
| All-time high | $0.0768 (Feb 14, 2024) |
| All-time low | $0.0523 (Nov 20, 2024) |
| 52-week high | $0.0764 |
| 52-week low | $0.0695 |
| Median price | $0.0707 |
| Average price | $0.0705 |
| Largest weekly change | -30.9% (Nov 20, 2024) |
| Weeks tracked | 124 |
| Tracking since | Feb 14, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LORAZEPAM 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 2 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.0696 per EA (NDC 13107008505), effective Jun 24, 2026.
How has the price of LORAZEPAM 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 2 MG TABLET has declined 9.4%. It has been tracked across 124 weekly CMS publications since Feb 14, 2024.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 2 MG TABLET?
Since Feb 14, 2024, the NADAC for LORAZEPAM 2 MG TABLET has ranged from a low of $0.0523 (Nov 20, 2024) to a high of $0.0768 (Feb 14, 2024), with a median of $0.0707 per EA.
Are there cheaper alternatives to LORAZEPAM 2 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as LORAZEPAM 2 MG TABLET, but none are currently priced below it.
Who manufactures LORAZEPAM 2 MG TABLET?
LORAZEPAM 2 MG TABLET (NDC 13107008505) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification